BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 192,975,286
- Total 13F shares
- 178,653,463
- Share change
- -391,556
- Total reported value
- $15,494,286,845
- Put/Call ratio
- 90%
- Price per share
- $86.68
- Number of holders
- 548
- Value change
- -$55,787,524
- Number of buys
- 256
- Number of sells
- 249
Quarterly Holders Quick Answers
What is CUSIP 09061G101?
CUSIP 09061G101 identifies BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09061G101:
Top shareholders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
9.5%
|
18,243,429
|
$1,773,991,036 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.1%
|
17,533,246
|
$1,704,932,840 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
7.6%
|
14,638,576
|
$1,423,455,129 | — | 31 Mar 2023 | |
| DODGE & COX |
13F
|
Company |
7.4%
|
14,329,313
|
$1,393,382,396 | — | 31 Mar 2023 | |
| Capital Research Global Investors |
13F
|
Company |
3.7%
|
7,208,959
|
$700,959,243 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
3.1%
|
6,066,318
|
$589,888,762 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.6%
|
4,938,346
|
$480,204,855 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2%
|
3,945,000
|
$383,611,800 | — | 31 Mar 2023 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2%
|
3,810,248
|
$370,508,516 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.8%
|
3,515,830
|
$341,879,309 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.8%
|
3,437,284
|
$334,250,530 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
1.5%
|
2,884,483
|
$280,487,127 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
2,662,123
|
$258,492,246 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.3%
|
2,553,926
|
$248,343,097 | — | 31 Mar 2023 | |
| PARNASSUS INVESTMENTS, LLC |
13F
|
Company |
1.2%
|
2,338,529
|
$227,398,560 | — | 31 Mar 2023 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
1.1%
|
2,168,617
|
$210,876,317 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
1.1%
|
2,096,775
|
$203,890,400 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
2,079,649
|
$202,225,072 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
1.1%
|
2,054,522
|
$199,781,719 | — | 31 Mar 2023 | |
| Palo Alto Investors LP |
13F
|
Company |
0.95%
|
1,831,035
|
$178,049,843 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.94%
|
1,817,010
|
$176,686,052 | — | 31 Mar 2023 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.84%
|
1,615,210
|
$157,063,020 | — | 31 Mar 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.83%
|
1,604,826
|
$156,053,280 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.68%
|
1,305,438
|
$126,940,791 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.67%
|
1,294,047
|
$125,834,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
1,259,032
|
$122,428,272 | — | 31 Mar 2023 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.62%
|
1,187,327
|
$115,455,677 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.6%
|
1,166,797
|
$113,459,551 | — | 31 Mar 2023 | |
| Amundi |
13F
|
Individual |
0.6%
|
1,167,321
|
$112,728,189 | — | 31 Mar 2023 | |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ |
13F
|
Company |
0.59%
|
1,144,811
|
$111,321,422 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.59%
|
1,131,039
|
$109,982,233 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
1,128,879
|
$109,772,228 | — | 31 Mar 2023 | |
| Manning & Napier Group, LLC |
13F
|
Company |
0.57%
|
1,100,718
|
$107,033,818 | — | 31 Mar 2023 | |
| Gestion Carmignac |
13F
|
Individual |
0.54%
|
1,044,371
|
$101,552,681 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.52%
|
1,009,614
|
$98,174,865 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.46%
|
888,483
|
$86,396,217 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.44%
|
857,029
|
$83,337,501 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.44%
|
850,814
|
$82,733,153 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.4%
|
781,071
|
$75,951,000 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.38%
|
737,600
|
$71,724,224 | — | 31 Mar 2023 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.38%
|
729,446
|
$70,930,000 | — | 31 Mar 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.36%
|
685,295
|
$66,638,085 | — | 31 Mar 2023 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.35%
|
674,108
|
$65,550,261 | — | 31 Mar 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.35%
|
673,060
|
$65,448,354 | — | 31 Mar 2023 | |
| DnB Asset Management AS |
13F
|
Company |
0.32%
|
618,247
|
$60,118,338 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.32%
|
614,122
|
$59,709,353 | — | 31 Mar 2023 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.31%
|
598,521
|
$58,200,182 | — | 31 Mar 2023 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.31%
|
589,244
|
$57,124,061 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.3%
|
586,295
|
$57,011,000 | — | 31 Mar 2023 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.3%
|
583,900
|
$56,778,436 | — | 31 Mar 2023 |
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) as of Q2 2023
As of 30 Jun 2023,
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) was held by
548 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
178,653,463 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, Dodge & Cox, BlackRock Inc., Capital Research Global Investors, STATE STREET CORP, AMERIPRISE FINANCIAL INC, VIKING GLOBAL INVESTORS LP, Avoro Capital Advisors LLC, and BAKER BROS. ADVISORS LP.
This page lists
551
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
544
Q2 2023 holders
548
Holder diff
4
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.